Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10594267 | Bioorganic & Medicinal Chemistry Letters | 2012 | 6 Pages |
Abstract
We report the discovery of a series of 4-aryl-2-aminoalkylpyrimidine derivatives as potent and selective JAK2 inhibitors. High throughput screening of our in-house compound library led to the identification of hit 1, from which optimization resulted in the discovery of highly potent and selective JAK2 inhibitors. Advanced lead 10d demonstrated a significant dose-dependent pharmacodynamic and antitumor effect in a mouse xenograft model. Based upon the desirable profile of 10d (XL019) it was advanced into clinical trials.
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Timothy Forsyth, Patrick C. Kearney, Byung Gyu Kim, Henry W.B. Johnson, Naing Aay, Arlyn Arcalas, David S. Brown, Vicky Chan, Jeff Chen, Hongwang Du, Sergey Epshteyn, Adam A. Galan, Tai P. Huynh, Mohamed A. Ibrahim, Brian Kane, Elena S. Koltun,